Carters Inc (CRI) insider trading.
In Q3 2026, insiders at Carters Inc reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-28
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Eagle Jevin | Director | 1 | 0 | 0 |
| Smith Karen Marie | Officer · Chief Supply Chain Officer | 1 | 0 | 0 |
| Peterson Allison | Officer · Chf. Retail & Digital Ofc. | 1 | 0 | 0 |
| Crockett Sarah | Officer · Chief Marketing Officer | 1 | 0 | 0 |
| Scanlon Emily DeHaven Evert | Officer · Chief Strategy Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-25 | Eagle Jevin | A (A) | 15 | $0 | 27,035 | Form 4 |
| 2026-08-12 | Smith Karen Marie | F (D) | 1,124 | $39.06 | 54,451 | Form 4 |
| 2026-08-09 | Peterson Allison | F (D) | 4,426 | $39.96 | 63,297 | Form 4 |
| 2026-08-08 | Crockett Sarah | F (D) | 2,842 | $39.96 | 41,390 | Form 4 |
| 2026-08-08 | Scanlon Emily DeHaven Evert | F (D) | 8,743 | $39.96 | 88,725 | Form 4 |
Transaction codes in this quarter
Get CRI insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1060822&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CRI company page · Carters Inc on SEC.gov
Questions
Are insiders buying or selling Carters Inc (CRI)?
In Q3 2026, insiders at Carters Inc reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Carters Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cri.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.